-
Published12/07/2024
-
Deadline21/08/2024
-
Opening of tenders21/08/2024
-
Awarded23/10/2024
-
Today25/04/2025
Utilities
Synthetic genes and DNA fragments
The object of the tender process are synthetic genes and DNA fragments (later also "Supplies"). The object of the tender process and requirements relating to the supplies are discussed in more detail in the invitation to tender documents. The objective is to find professional suppliers that can guarantee a high standard of quality and who is capable of providing the Supplies in its entirety. The objective is to find professional suppliers that can guarantee a high standard of quality and who is capable of providing the supplies as described in the invitation to tender. VTT will choose two (2) suppliers from among the tenderers. The selection criterion for the contract will be economic advantageous, lowest price. All tenders that fulfil the criteria specified in the invitation to tender shall be compared against each other on the basis of said criteria and the weightings indicated. The tender shall be identified on the basis of the lowest price.
https://tarjouspalvelu.fi/vtt?id=516548&tpk=41691776-6c81-4651-9bbd-25bf48355e52
https://tarjouspalvelu.fi/vtt?id=516548&tpk=41691776-6c81-4651-9bbd-25bf48355e52
Postal address:
Town: Espoo
Postal code: 02101
Country:
Official name: GenScript Biotech Netherlands BV
Postal address:
Town: Leiden
Postal code: 2333CG
Country:
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.